Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer

NCT05794659 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Ovarian Cancer

Interventions

BIOLOGICAL: AST-201
DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Placebo
DRUG: rhuGM-CSF(Granulocyte-Macrophage Colony-Stimulating Factor)

Sponsor

Aston Sci. Inc.